{"schema_version":"secwatch.filing_event.v1","accession":"0001048477-25-000098","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.197338+00:00","generated_at":"2026-05-17T15:07:03.309295+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"BioMarin Chief Accounting Officer Erin Burkhart resigns; CFO to serve as interim principal accounting officer","bullets":["Erin Burkhart notified her resignation as Chief Accounting Officer, effective September 2, 2025; departure is voluntary with no disagreement.","BioMarin will conduct a search for a successor; if none is appointed by the Effective Date, CFO Brian Mueller will serve as principal accounting officer.","Mueller will remain Executive VP and CFO with no additional compensation or adjustments for assuming the principal accounting officer duties."],"urls":{"canonical":"https://secwatch.observer/filing/0001048477-25-000098","json":"https://secwatch.observer/filing/0001048477-25-000098.json","markdown":"https://secwatch.observer/filing/0001048477-25-000098.md","text":"https://secwatch.observer/filing/0001048477-25-000098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/0001048477-25-000098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000098/bmrn-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:07:03.309295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}